# Cytokine Profile in Children With Celiac Disease

> **NCT02244047** · PHASE1,PHASE2 · COMPLETED · sponsor: **University Medical Centre Maribor** · enrollment: 66 (actual)

## Conditions studied

- Celiac Disease

## Interventions

- **DRUG:** Bifidobacterium breve
- **DRUG:** Placebo (for Bifidobacterium breve)

## Key facts

- **NCT ID:** NCT02244047
- **Lead sponsor:** University Medical Centre Maribor
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-10
- **Primary completion:** 2014-06
- **Final completion:** 2014-06
- **Target enrollment:** 66 (ACTUAL)
- **Last updated:** 2014-09-18

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02244047

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02244047, "Cytokine Profile in Children With Celiac Disease". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT02244047. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*